SIG-1451: A Topical Anti-Inflammatory New Chemical Entity for Atopic Dermatitis
April 2017
in “
Journal of Investigative Dermatology
”
SIG-1451 atopic dermatitis non-steroidal anti-inflammatory drug pro-inflammatory cytokines IL-4 IL-6 TSLP PBMCs endothelial cells NHEKS S. aureus AN2728 TPA edema oxazolone delayed type hypersensitivity DTH Investigational New Drug IND AD non-steroidal anti-inflammatory cytokines Staphylococcus aureus acute inflammation hypersensitivity
Studysummary In laboratory tests and mouse models, this study found that the novel IPC analog SIG-1451 may offer potent anti-inflammatory effects for treating allergic skin inflammation, potentially outperforming some current therapies in specific inflammatory phases.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer